Profile data is unavailable for this security.
About the company
Centene Corporation is a healthcare company. The Company provides fully integrated services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Its segments include Medicaid, Medicare, Commercial and Other. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
- Revenue in USD (TTM)169.28bn
- Net income in USD3.45bn
- Incorporated2001
- Employees60.50k
- LocationCentene Corp7700 Forsyth BlvdST. LOUIS 63105-1807United StatesUSA
- Phone+1 (314) 725-4477
- Fax+1 (302) 655-5049
- Websitehttps://www.centene.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemed Corp | 2.49bn | 308.74m | 8.18bn | 15.70k | 27.24 | 6.90 | 22.00 | 3.29 | 20.53 | 20.53 | 165.47 | 81.09 | 1.44 | 175.37 | 10.75 | 158,585.30 | 17.88 | 19.20 | 21.43 | 24.05 | 34.82 | 35.20 | 12.40 | 12.78 | 1.70 | -- | 0.0004 | 8.19 | 7.37 | 4.63 | 10.82 | 6.55 | -1.35 | 7.74 |
| Ensign Group Inc | 4.42bn | 309.42m | 8.82bn | 39.30k | 28.94 | 4.58 | 22.12 | 1.99 | 5.30 | 5.30 | 75.76 | 33.48 | 0.9756 | -- | 8.02 | 112,553.50 | 6.83 | 6.66 | 8.11 | 8.11 | 21.32 | 22.30 | 7.00 | 6.87 | -- | -- | 0.0697 | 5.65 | 14.24 | 15.91 | 42.30 | 26.58 | -5.78 | 4.78 |
| Davita Inc | 12.97bn | 859.61m | 10.70bn | 76.00k | 14.02 | -- | 5.66 | 0.8248 | 10.10 | 10.10 | 152.64 | -3.46 | 0.7507 | 59.12 | 5.28 | 170,638.50 | 6.81 | 6.09 | 9.26 | 8.06 | 32.46 | 31.21 | 9.08 | 8.69 | 1.20 | 4.05 | 0.8544 | -- | 5.56 | 2.39 | 35.40 | 5.82 | -6.24 | -- |
| Hims & Hers Health Inc | 1.78bn | 164.40m | 11.06bn | 1.64k | 72.25 | 20.11 | 59.19 | 6.20 | 0.6839 | 0.6839 | 7.40 | 2.46 | 2.66 | 7.73 | 267.34 | 1,090,014.00 | 24.54 | -3.91 | 34.03 | -4.74 | 77.04 | -- | 9.21 | -2.35 | 1.32 | -- | 0.00 | -- | 69.33 | -- | 635.28 | 155.96 | -- | -- |
| Universal Health Services Inc | 16.08bn | 1.20bn | 11.48bn | 86.00k | 10.00 | 1.69 | 6.34 | 0.7135 | 17.81 | 17.81 | 239.04 | 105.30 | 1.11 | -- | 6.83 | 187,024.10 | 8.43 | 6.68 | 10.01 | 7.94 | -- | -- | 7.58 | 6.62 | 1.23 | 9.84 | 0.4031 | 5.63 | 10.82 | 6.82 | 59.17 | 7.04 | 7.56 | 5.92 |
| Encompass Health Corp | 5.51bn | 494.00m | 12.34bn | 23.56k | 25.26 | 5.70 | 12.79 | 2.24 | 4.84 | 4.82 | 53.99 | 21.44 | 0.8565 | -- | 8.87 | 233,941.60 | 10.20 | 6.72 | 13.26 | 8.39 | 95.60 | 95.41 | 11.91 | 9.53 | -- | 7.09 | 0.457 | 26.04 | 11.91 | 3.13 | 26.02 | 4.94 | 9.72 | -10.27 |
| Molina Healthcare Inc | 41.87bn | 1.18bn | 16.10bn | 18.00k | 14.35 | 3.72 | 11.79 | 0.3846 | 20.70 | 20.70 | 737.08 | 79.81 | 2.62 | -- | 12.24 | 2,325,889.00 | 7.37 | 7.30 | 15.44 | 15.96 | 15.22 | 15.66 | 2.81 | 2.86 | -- | 12.81 | 0.4663 | 0.00 | 19.31 | 19.29 | 8.07 | 9.85 | 11.90 | -- |
| Tenet Healthcare Corp | 20.52bn | 1.46bn | 16.13bn | 74.48k | 11.48 | 3.86 | 5.09 | 0.786 | 15.12 | 15.12 | 212.60 | 45.01 | 0.7058 | 9.81 | 6.66 | 275,510.20 | 8.09 | 6.32 | 11.88 | 8.98 | 82.33 | 82.75 | 11.46 | 8.84 | 1.70 | 6.08 | 0.6035 | 0.00 | 0.5694 | 2.26 | 423.73 | -- | 6.80 | -- |
| Quest Diagnostics Inc | 10.16bn | 892.00m | 19.85bn | 45.00k | 22.62 | 2.87 | 13.82 | 1.95 | 7.86 | 7.86 | 89.50 | 61.87 | 0.6829 | 36.71 | 7.45 | 225,733.30 | 6.18 | 8.96 | 7.13 | 10.40 | 33.15 | 36.15 | 9.05 | 12.55 | 1.31 | 6.81 | 0.4541 | 25.68 | 6.70 | 5.02 | 1.88 | 0.7317 | 1.22 | 6.90 |
| Labcorp Holdings Inc | 13.18bn | 730.80m | 21.81bn | 70.00k | 30.05 | 2.63 | 15.72 | 1.66 | 8.67 | 8.67 | 156.36 | 99.13 | 0.7721 | 19.73 | 5.88 | 188,248.60 | 4.29 | 6.16 | 5.21 | 7.33 | 27.89 | 32.18 | 5.55 | 9.17 | 1.60 | 5.48 | 0.404 | -- | 6.97 | 2.40 | 96.73 | -1.96 | 4.13 | -- |
| Natera Inc | 1.83bn | -189.76m | 22.93bn | 4.42k | -- | 18.42 | -- | 12.53 | -1.47 | -1.47 | 14.28 | 9.12 | 1.14 | 14.98 | 6.03 | 413,878.80 | -11.86 | -30.60 | -15.01 | -38.82 | 61.79 | 51.43 | -10.36 | -40.61 | 3.74 | -- | 0.0609 | -- | 56.75 | 41.20 | 56.20 | -- | 72.97 | -- |
| Centene Corp | 169.28bn | 3.45bn | 26.87bn | 60.50k | 8.04 | 0.9622 | 5.72 | 0.1587 | 6.72 | 6.72 | 329.55 | 56.11 | 2.00 | -- | 8.62 | 2,798,083.00 | 4.07 | 2.79 | 6.93 | 4.42 | 10.27 | 11.27 | 2.04 | 1.48 | -- | 5.26 | 0.3954 | 0.00 | 5.89 | 16.92 | 22.32 | 20.13 | -2.48 | -- |
| Humana Inc | 120.26bn | 1.71bn | 29.19bn | 65.68k | 17.10 | 1.64 | 10.54 | 0.2428 | 14.14 | 14.14 | 996.52 | 147.08 | 2.38 | -- | -- | 1,831,029.00 | 3.62 | 6.19 | -- | -- | -- | -- | 1.52 | 2.69 | -- | 5.47 | 0.4275 | 15.11 | 10.70 | 12.66 | -51.51 | -14.92 | -4.82 | 10.49 |
Data as of Jun 30 2025. Currency figures normalised to Centene Corp's reporting currency: US Dollar USD
42.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 55.19m | 11.13% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 27.42m | 5.53% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 25.36m | 5.11% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 22.67m | 4.57% |
| Harris Associates LPas of 31 Mar 2025 | 21.14m | 4.26% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2025 | 14.91m | 3.01% |
| Geode Capital Management LLCas of 31 Mar 2025 | 12.93m | 2.61% |
| AQR Capital Management LLCas of 31 Mar 2025 | 11.05m | 2.23% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2025 | 10.92m | 2.20% |
| Wellington Management Co. LLPas of 31 Mar 2025 | 9.49m | 1.91% |
More ▼
Data from 31 Dec 2024 - 31 Mar 2025Source: FactSet Research Systems Inc.
